MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ejpn.2022.06.009

Медицинская библиотека · European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society · 2022

Rituximab in juvenile myasthenia gravis-an international cohort study and literature review.

Ramdas Sithara, Della Marina Adela, Ryan Monique M, McWilliam Kenneth, Klein Andrea, Jacquier David, Alabaf Setareh, Childs Anne-Marie, Parasuraman Deepak, Beeson David, Palace Jacqueline, Jungbluth Heinz

СтатьяОбзорПеревод пока не подготовлен

Аннотация

Juvenile myasthenia gravis (JMG) is a rare, antibody-mediated disorder of the neuromuscular junction. Treatment strategies in JMG are largely informed by adult MG treatments as the pathophysiology is similar. Rituximab is increasingly considered as a treatment option in refractory JMG but has not yet been systematically investigated in this patient group We conducted a retrospective study from five international centres with expertise in paediatric myasthenia. 10 JMG patients treated with rituximab were identified. Following rituximab treatment all patients had a reduction in JMG-related hospital admissions. At 24 month follow up, 6 patients (60%) had achieved complete stable remission or pharmacological remission and 7 patients were able to reduce immunomodulatory treatment(s). The main side-effect was infusion-related reactions (30%) which resolved in all patients with symptomatic treatment. We compared our cohort to previously reported JMG cases treated with rituximab and noted similar response rates but a slightly higher side-effect profile. Rituximab is a safe and effective treatment option in moderate to severe JMG and most patients have an improvement in MG symptoms post treatment.

Для цитирования: Ramdas Sithara, Della Marina Adela, Ryan Monique M, McWilliam Kenneth, Klein Andrea, Jacquier David, Alabaf Setareh, Childs Anne-Marie, Parasuraman Deepak, Beeson David, Palace Jacqueline, Jungbluth Heinz. Rituximab in juvenile myasthenia gravis-an international cohort study and literature review.. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society. 2022. DOI: 10.1016/j.ejpn.2022.06.009.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.